tiprankstipranks
Trending News
More News >
Silo Pharma Inc (SILO)
:SILO
US Market
Advertisement

Silo Pharma (SILO) Price & Analysis

Compare
185 Followers

SILO Stock Chart & Stats


Silo Pharma News

SILO FAQ

What was Silo Pharma Inc’s price range in the past 12 months?
Silo Pharma Inc lowest stock price was $0.41 and its highest was $3.37 in the past 12 months.
    What is Silo Pharma Inc’s market cap?
    Silo Pharma Inc’s market cap is $4.61M.
      When is Silo Pharma Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Silo Pharma Inc’s earnings last quarter?
      Currently, no data Available
      Is Silo Pharma Inc overvalued?
      According to Wall Street analysts Silo Pharma Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Silo Pharma Inc pay dividends?
        Silo Pharma Inc does not currently pay dividends.
        What is Silo Pharma Inc’s EPS estimate?
        Silo Pharma Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Silo Pharma Inc have?
        Silo Pharma Inc has 7,207,792 shares outstanding.
          What happened to Silo Pharma Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Silo Pharma Inc?
          Currently, no hedge funds are holding shares in SILO

          Company Description

          Silo Pharma Inc

          Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

          Silo Pharma (SILO) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          180 Life Sciences
          Creative Medical Technology Holdings
          Alzamend Neuro
          Longevity Health Holdings
          Klotho Neurosciences

          Ownership Overview

          2.82%0.70%2.00%91.42%
          2.00% Other Institutional Investors
          91.42% Public Companies and Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis